retatrutide triple agonist gip glp-1 glucagon 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in

Retatrutide Isn't Magic It's an Amplifier Retatrutide is one of the most powerful metabolic tools available today but it doesn't work alone. Think of it like a volume knob Thailand's Food and Drug Administration is reclassifying GLP 1 weight loss pens as a special controlled drug. This move aims to curb the rising misuse of "slimming pens" for cosmetic weight loss promoted online. The FDA has approved Foundayo, a new oral GLP 1 receptor agonist from Eli Lilly, built on a non peptide small molecule called orforglipron rather than a traditional peptide structure. Across clinical trials, it Members across the state did phenomenal work to prevent harmful increases in health care costs for public employees. But while the Group Insurance Commission backed off from raising copays and deductibles, it did